All-trans retinoic acid (ATRA) potentiates the in vitro inhibitory effects of IFN-alpha in parental (32D) and p210-bcr/abl transfected (LG7) murine myeloid cell lines.
Russo
D
D
Tell
G
G
Marin
L
L
Tiribelli
M
M
Santucci
M A
MA
Pucillo
C
C
D000818:Animals; D002455:Cell Division / Q000187:drug effects*; D002460:Cell Line; D004359:Drug Therapy, Combination; D016044:Fusion Proteins, bcr-abl / Q000235:genetics; D016898:Interferon-alpha / Q000187:drug effects* / Q000494:pharmacology; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D051379:Mice; D015513:Oncogene Proteins; D010677:Philadelphia Chromosome; D014162:Transfection; D014212:Tretinoin / Q000494:pharmacology*
D016898:Interferon-alpha; D015513:Oncogene Proteins; D014212:Tretinoin; D016044:Fusion Proteins, bcr-abl